Using a Facebook chatbot to share health information
Part of Cancer, Immune system & allergy, Infections, Skin clinical trials.
This study tests whether a Facebook Messenger chatbot can provide helpful health information for different conditions. You may help researchers check if people can use the chatbot and understand the information.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 14 or older
- Be able to read and understand English and/or French
- Be able to understand the study and say yes to participate (informed consent)
- Have access to a smartphone, tablet, or computer and the internet (or mobile data)
- Be willing to use a Facebook Messenger chatbot
- Have or be willing to create a personal Facebook account and agree to Facebook’s privacy rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program to help people who face barriers get routine mammograms. If you are going for a regular breast cancer screening, you may be able to join.
This study tests an AI chatbot that provides support to people who have finished breast cancer treatment. It may help you manage survivorship and improve your well-being.
This study uses a smartphone app and biological markers to predict cancer risk. It is testing whether digital and molecular data can help identify cancer earlier, especially in women with a history of certain cancers.
This study tests a phone chatbot designed to encourage HIV testing. You may benefit by getting reminders and guidance to help you consider HIV testing after recent condomless sex.
This trial tests a chatbot that provides information and support about fertility concerns to young women who have had cancer. It aims to help them feel more in control and less worried about their reproductive health.
This trial tests a chatbot that gives support and advice to young adults who have finished cancer treatment. It aims to help you manage symptoms and side effects through an easy-to-use online tool.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.